Resorb3D
Industry: 3D-printed reconstructive devices
Tracheal splints, ear scaffolds and other devices used in head and neck surgeries have a major limitation: Their design can’t be individualized to fit a specific patient. As a result, implanting them often requires multiple surgeries, and patients fail to find a comfortable fit long-term, which can lead to tissue erosion, infection and debilitating discomfort.
Resorb3D is developing a platform to produce 3D-printed bio-tissue devices, making it easier to implant them in surgery and improving their long-term effectiveness.
As of early 2023, an airway support device had already been used to treat 25 patients of tracheomalacia to date, and two-year follow-ups showed that the device improved quality of life and reduced hospital stays.
The next phase of the company’s work involves implementing the Good Manufacturing Processes for the device, an FDA-required step before regulatory approval.
